Search Within

Larry Norton

Formats
  1. Journal Article (411)
  2. Meeting Abstract (297)
  3. Book Section (21)
  4. Conference Paper (16)
  5. Editorial (8)
  6. Guidelines (3)
  7. Correspondence (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (762)
  2. Breast Medicine Service (762)
  3. Department of Medicine (762)
  4. Solid Tumor Oncology Division (762)
  5. Survivorship Research (393)
  6. GSK Faculty (224)

More Groups

People
  1. Clifford Hudis (293)
  2. Edi Brogi (115)
  3. Andrew Seidman (99)
  4. Sujata Patil (97)
  5. Mark Robson (90)
  6. Hannah Wen (83)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (18)
  4. 2022 (16)
  5. 2021 (13)
  6. 2020 (26)

More Years

Publications
  1. Journal of Clinical Oncology (156)
  2. Cancer Research (79)
  3. Breast Cancer Research and Treatment (48)
  4. Clinical Cancer Research (31)
  5. Laboratory Investigation (26)
  6. Modern Pathology (24)

More Publications

Publishers
  1. American Society of Clinical Oncology (160)
  2. American Association for Cancer Research (125)
  3. Nature Publishing Group (77)
  4. Springer (61)
  5. Oxford University Press (50)
  6. Elsevier Inc. (43)

More Publishers

Results (762)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Modi, S.; Drullinsky, P.; Syldor, A.; Patil, S.; Seidman, A.; Norton, L.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Phase II trial of dasatinib in combination with weekly paclitaxel for patients with metastatic breast carcinoma
    Meeting Abstract

    Morris, P. G.; Lake, D.; McArthur, H. L.; Gilewski, T.; Dang, C.; Chaim, J.; Patl, S.; Lim, K.; Norton, L.; Hudis, C. A.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • PAM50 gene signature is prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy
    Meeting Abstract

    Liu, M. C.; Pitcher, B. N.; Mardis, E. R.; Davies, S. R.; Snider, J. E.; Vickery, T.; Reed, J. P.; DeSchryver, K.; Singh, B.; Friedman, P. N.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Translating mathematical modeling of tumor growth patterns into novel therapeutic approaches for breast cancer
    Journal Article

    Comen, E.; Morris, P. G.; Norton, L.
    Journal of Mammary Gland Biology and Neoplasia (2012)

    Fulltext@MSK | Save
  • DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors
    Journal Article

    Wen, Y. H.; Brogi, E.; Zeng, Z.; Akram, M.; Catalano, J.; Paty, P. B.; Norton, L.; Shia, J.
    American Journal of Surgical Pathology (2012)

    Fulltext@MSK | Save
  • Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer
    Journal Article

    Chandarlapaty, S.; Sakr, R. A.; Giri, D.; Patil, S.; Heguy, A.; Morrow, M.; Modi, S.; Norton, L.; Rosen, N.; Hudis, C.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Ongoing debate: Anthracyclines and adjuvant treatment of human epidermal growth factor receptor 2-positive breast cancer - Reply
    Journal Article

    Burstein, H. J.; Piccart-Gebhart, M. J.; Perez, E. A.; Hortobagyi, G. N.; Wolmark, N.; Albain, K. S.; Norton, L.; Winer, E. P.; Hudis, C. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Six cycles of doxorubicin and cyclophosphamide or paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101
    Journal Article

    Shulman, L. N.; Cirrincione, C. T.; Berry, D. A.; Becker, H. P.; Perez, E. A.; O'Regan, R.; Martino, S.; Atkins, J. N.; Mayer, E.; Schneider, C. J.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?
    Journal Article

    Hudis, C. A.; Citron, M. L.; Muss, H.; Norton, L.; Winer, E. P.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Id4 protein is highly expressed in triple-negative breast carcinomas: Possible implications for BRCA1 downregulation
    Journal Article

    Wen, Y. H.; Ho, A.; Patil, S.; Akram, M.; Catalano, J.; Eaton, A.; Norton, L.; Benezra, R.; Brogi, E.
    Breast Cancer Research and Treatment (2012)

    Fulltext@MSK | Save